132 related articles for article (PubMed ID: 20198479)
21. The role of amyloid beta peptide 42 in Alzheimer's disease.
Findeis MA
Pharmacol Ther; 2007 Nov; 116(2):266-86. PubMed ID: 17716740
[TBL] [Abstract][Full Text] [Related]
22. Intraneuronal Abeta42 accumulation in Down syndrome brain.
Mori C; Spooner ET; Wisniewsk KE; Wisniewski TM; Yamaguch H; Saido TC; Tolan DR; Selkoe DJ; Lemere CA
Amyloid; 2002 Jun; 9(2):88-102. PubMed ID: 12440481
[TBL] [Abstract][Full Text] [Related]
23. NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production.
Valerio A; Boroni F; Benarese M; Sarnico I; Ghisi V; Bresciani LG; Ferrario M; Borsani G; Spano P; Pizzi M
Eur J Neurosci; 2006 Apr; 23(7):1711-20. PubMed ID: 16623827
[TBL] [Abstract][Full Text] [Related]
24. Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons.
Clifford PM; Zarrabi S; Siu G; Kinsler KJ; Kosciuk MC; Venkataraman V; D'Andrea MR; Dinsmore S; Nagele RG
Brain Res; 2007 Apr; 1142():223-36. PubMed ID: 17306234
[TBL] [Abstract][Full Text] [Related]
25. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
[TBL] [Abstract][Full Text] [Related]
26. Amyloid and Tau accumulate in the brains of aged hydrocephalic rats.
Silverberg GD; Miller MC; Machan JT; Johanson CE; Caralopoulos IN; Pascale CL; Heile A; Klinge PM
Brain Res; 2010 Mar; 1317():286-96. PubMed ID: 20045398
[TBL] [Abstract][Full Text] [Related]
27. Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau.
Lewczuk P; Esselmann H; Otto M; Maler JM; Henkel AW; Henkel MK; Eikenberg O; Antz C; Krause WR; Reulbach U; Kornhuber J; Wiltfang J
Neurobiol Aging; 2004 Mar; 25(3):273-81. PubMed ID: 15123331
[TBL] [Abstract][Full Text] [Related]
28. Oligomerization partially explains the lowering of Abeta42 in Alzheimer's disease cerebrospinal fluid.
Englund H; Degerman Gunnarsson M; Brundin RM; Hedlund M; Kilander L; Lannfelt L; Pettersson FE
Neurodegener Dis; 2009; 6(4):139-47. PubMed ID: 19521063
[TBL] [Abstract][Full Text] [Related]
29. Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43).
Mann DM; Iwatsubo T; Cairns NJ; Lantos PL; Nochlin D; Sumi SM; Bird TD; Poorkaj P; Hardy J; Hutton M; Prihar G; Crook R; Rossor MN; Haltia M
Ann Neurol; 1996 Aug; 40(2):149-56. PubMed ID: 8773595
[TBL] [Abstract][Full Text] [Related]
30. Adhesion molecule L1 binds to amyloid beta and reduces Alzheimer's disease pathology in mice.
Djogo N; Jakovcevski I; Müller C; Lee HJ; Xu JC; Jakovcevski M; Kügler S; Loers G; Schachner M
Neurobiol Dis; 2013 Aug; 56():104-15. PubMed ID: 23639788
[TBL] [Abstract][Full Text] [Related]
31. Cerebellar diffuse amyloid plaques are derived from dendritic Abeta42 accumulations in Purkinje cells.
Wang HY; D'Andrea MR; Nagele RG
Neurobiol Aging; 2002; 23(2):213-23. PubMed ID: 11804705
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer's disease hippocampi.
Rice AC; Keeney PM; Algarzae NK; Ladd AC; Thomas RR; Bennett JP
J Alzheimers Dis; 2014; 40(2):319-30. PubMed ID: 24448779
[TBL] [Abstract][Full Text] [Related]
33. A novel approach for Aβ₁₋₄₀ quantification using immuno-PCR.
Hashimoto M; Aoki M; Winblad B; Tjernberg LO
J Neurosci Methods; 2012 Apr; 205(2):364-7. PubMed ID: 22327103
[TBL] [Abstract][Full Text] [Related]
34. Serum amyloid beta protein in young and elderly depression: a pilot study.
Kita Y; Baba H; Maeshima H; Nakano Y; Suzuki T; Arai H
Psychogeriatrics; 2009 Dec; 9(4):180-5. PubMed ID: 20377819
[TBL] [Abstract][Full Text] [Related]
35. Wild-type, Flemish, and Dutch amyloid-β exhibit different cytotoxicities depending on Aβ40 to Aβ42 interaction time and concentration ratio.
Shahnawaz M; Sharoar MG; Shin SY; Park IS
J Pept Sci; 2013 Sep; 19(9):545-53. PubMed ID: 23853087
[TBL] [Abstract][Full Text] [Related]
36. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.
D'Andrea MR; Nagele RG
Curr Pharm Des; 2006; 12(6):677-84. PubMed ID: 16472157
[TBL] [Abstract][Full Text] [Related]
37. Consistent immunohistochemical detection of intracellular beta-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex.
D'Andrea MR; Nagele RG; Wang HY; Lee DH
Neurosci Lett; 2002 Nov; 333(3):163-6. PubMed ID: 12429373
[TBL] [Abstract][Full Text] [Related]
38. Differential Effects of Alzheimer's Disease Aβ40 and 42 on Endocytosis and Intraneuronal Trafficking.
Omtri RS; Thompson KJ; Tang X; Gali CC; Panzenboeck U; Davidson MW; Kalari KR; Kandimalla KK
Neuroscience; 2018 Mar; 373():159-168. PubMed ID: 29337241
[TBL] [Abstract][Full Text] [Related]
39. Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery.
Omtri RS; Davidson MW; Arumugam B; Poduslo JF; Kandimalla KK
Mol Pharm; 2012 Jul; 9(7):1887-97. PubMed ID: 22574751
[TBL] [Abstract][Full Text] [Related]
40. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.
Fassbender K; Simons M; Bergmann C; Stroick M; Lutjohann D; Keller P; Runz H; Kuhl S; Bertsch T; von Bergmann K; Hennerici M; Beyreuther K; Hartmann T
Proc Natl Acad Sci U S A; 2001 May; 98(10):5856-61. PubMed ID: 11296263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
